# Q1 Advisor Review: Privacy-Preserving Phenotype Matching

**Date:** December 11, 2024
**Student:** Patrick Walsh
**Advisor:** Professor Stephen Montgomery
**Program:** Stanford CS Honors Thesis 2024-2025

---

## Overall Assessment: Strong Foundation

Patrick, you've made excellent progress in Q1. The project has a solid foundation with:
- Working code (1,800+ lines)
- Professional documentation
- Clear evaluation framework
- Standards compliance (GA4GH Phenopackets)

**Grade Equivalent:** A-

---

## Detailed Feedback

### What's Working Well

1. **Code Quality**: The modular architecture will scale well. Good use of type hints, docstrings, and separation of concerns.

2. **Standards Adoption**: Starting with GA4GH Phenopackets was the right call. This positions the work for real-world adoption.

3. **Evaluation Framework**: Having Recall@k metrics from day one shows experimental rigor.

4. **Creative Problem-Solving**: The synthetic data generator is well-designed and saved the quarter when data access was delayed.

### Areas Requiring Improvement

1. **Disease Diversity**: ✅ *ADDRESSED* - Now expanded from 4 to 19 rare diseases across multiple organ systems.

2. **HPO Labels**: ✅ *ADDRESSED* - Implemented proper ontology lookup with curated fallback.

3. **Semantic Similarity**: ✅ *ADDRESSED* - Added graph-based similarity module with Resnik, Lin, and Jiang-Conrath metrics.

4. **External Data Integration**: ✅ *ADDRESSED* - Created utilities for HPOA, OMIM, Orphanet, and ClinVar integration.

---

## Innovation Suggestions for Publication-Quality Work

### 1. Implement Federated Learning Component
Rather than just PSI for secure matching, consider implementing a federated similarity learning component. This would allow institutions to collaboratively train phenotype embeddings without sharing raw data.

**Key paper to read**: "Communication-Efficient Learning of Deep Networks from Decentralized Data" (McMahan et al., 2017)

### 2. Add Rare Disease Prioritization Scoring
Implement a LIRICAL-style scoring system that combines:
- Phenotype overlap score
- Information content weighting
- Phenotype frequency in disease
- Post-test probability calculation

This would make the tool useful for clinical diagnosis support, not just cohort matching.

### 3. Phenotype Embedding Space
Train or use pre-trained HPO embeddings (similar to word2vec for phenotypes). This would enable:
- More nuanced similarity computation
- Clustering analysis
- Anomaly detection for novel phenotype combinations

**Suggested approach**: Use node2vec on HPO graph or leverage PhenoGPT embeddings.

### 4. Multi-Modal Matching
Extend beyond phenotypes to include:
- Gene expression profiles (when available)
- Variant data (privacy-preserving)
- Demographic features (with appropriate DP)

---

## Suggested Data Sources

### Immediate Access (No Application Required)

| Source | Data Type | Access |
|--------|-----------|--------|
| **HPO Annotations (phenotype.hpoa)** | 9,000+ diseases, 500K+ annotations | Direct download |
| **Orphanet** | 6,000+ rare diseases with prevalence | Orphadata.com |
| **ClinVar** | Variant-disease associations | NCBI E-utilities |
| **OMIM** | Mendelian disease catalog | API (key required) |
| **Mondo Disease Ontology** | Unified disease nomenclature | Direct download |

### Pending Access (Apply Now for Q2/Q3)

| Source | Data Type | Timeline |
|--------|-----------|----------|
| **MIMIC-IV** | 300K+ ICU admissions with diagnoses | 2-4 weeks approval |
| **STARR-OMOP-deid** | Stanford de-identified EHR | 4-6 weeks approval |
| **UK Biobank** | 500K participants with phenotypes | 8-12 weeks approval |
| **All of Us** | NIH research program | 4-6 weeks approval |

### Rare Disease Registries (Specialized)

| Registry | Focus | Contact |
|----------|-------|---------|
| **RD-Connect** | European rare disease | rdconnect.eu |
| **GRDR** | Global Rare Diseases | ncats.nih.gov |
| **Patient registries** | Disease-specific | Via advocacy groups |

---

## Rare Diseases to Highlight

### Ultra-Rare (<1 in 1,000,000) - High Impact

1. **Progeria (HGPS)** - ✅ Already included
2. **Niemann-Pick Type C** - Neurological storage disorder
3. **Fibrodysplasia Ossificans Progressiva** - Muscle turns to bone
4. **Hutchinson-Gilford Progeria** - ✅ Already included
5. **Epidermolysis Bullosa (severe)** - ✅ Already included

### Diagnostic Odyssey Diseases (Commonly Misdiagnosed)

These are excellent for demonstrating matching value:

1. **Ehlers-Danlos Syndrome** - ✅ Already included (often missed)
2. **POTS (Postural Orthostatic Tachycardia)** - Needs profile
3. **Mast Cell Activation Syndrome** - Needs profile
4. **Hereditary Hemochromatosis** - Needs profile
5. **Wilson Disease** - Needs profile

### Diseases with Active Patient Advocacy

Including these could lead to real-world partnerships:

1. **Cystic Fibrosis** - ✅ Already included
2. **Sickle Cell Disease** - ✅ Already included
3. **Rett Syndrome** - ✅ Already included
4. **Huntington Disease** - ✅ Already included
5. **Duchenne Muscular Dystrophy** - Needs profile

---

## Quarter 2 Roadmap (Winter 2025)

### Weeks 1-3: Privacy Mechanisms

**Deliverable**: Working PSI implementation

Tasks:
- [ ] Implement OPRF-based PSI for phenotype set intersection
- [ ] Add differential privacy noise to aggregate counts
- [ ] Implement k-anonymity filtering (suppress if <k matches)
- [ ] Benchmark privacy-utility tradeoff

**Key metric**: Privacy budget (ε) vs Recall@20

### Weeks 4-6: Advanced Matching

**Deliverable**: Production-ready similarity pipeline

Tasks:
- [ ] Integrate graph-based similarity (Resnik, Lin, JC)
- [ ] Implement LSH-ANN for approximate nearest neighbor search
- [ ] Add phenotype embedding support
- [ ] Benchmark computational efficiency (target: <100ms per query)

**Key metric**: Query latency at 10K, 100K, 1M patients

### Weeks 7-8: Standards Integration

**Deliverable**: MME-compatible service

Tasks:
- [ ] Implement Matchmaker Exchange adapter
- [ ] Add Beacon v2 compatibility layer
- [ ] Create Docker containerization
- [ ] Write API documentation

**Key metric**: Successful MME match requests

### Weeks 9-10: Evaluation & Documentation

**Deliverable**: Winter quarter report

Tasks:
- [ ] Comprehensive privacy-utility experiments
- [ ] Cross-disease confusion analysis
- [ ] Write preliminary thesis chapter (Methods)
- [ ] Prepare midpoint presentation

---

## Quarter 3 Roadmap (Spring 2025)

### Weeks 1-4: Real Data Validation

**Deliverable**: Performance on real EHR data

Tasks:
- [ ] MIMIC-IV phenotype extraction and mapping
- [ ] STARR-OMOP cohort analysis (if approved)
- [ ] Compare synthetic vs real data performance
- [ ] Analyze phenotype heterogeneity in real data

### Weeks 5-7: Security Audit

**Deliverable**: Formal privacy analysis

Tasks:
- [ ] Membership inference attack evaluation
- [ ] Attribute inference simulation
- [ ] Collusion threat model testing
- [ ] Finalize privacy parameters

### Weeks 8-10: Thesis Completion

**Deliverable**: Submitted thesis + open-source release

Tasks:
- [ ] Complete all thesis chapters
- [ ] Prepare open-source release
- [ ] Create demonstration video
- [ ] Final presentation preparation

---

## Recommended Reading

### Privacy & Security
1. Dwork & Roth (2014). "Algorithmic Foundations of Differential Privacy"
2. Pinkas et al. (2018). "Scalable Private Set Intersection"
3. Aziz et al. (2017). "Privacy-preserving techniques for genomic data"

### Rare Disease Matching
4. Robinson et al. (2024). "LIRICAL: A clinical likelihood framework"
5. Smedley et al. (2015). "Exomiser: phenotype-driven prioritization"
6. Jacobsen et al. (2024). "HPO 2024 update"

### Federated Learning
7. McMahan et al. (2017). "Communication-Efficient Learning"
8. Kaissis et al. (2020). "Secure, privacy-preserving and federated ML in medical imaging"

---

## Action Items Before Next Meeting

1. **Apply for Data Access**: Submit MIMIC-IV and STARR-OMOP applications this week
2. **Literature Review**: Read the PSI papers (Pinkas et al.) and prepare implementation plan
3. **Generate Extended Dataset**: Create mixed cohort with all 19 diseases (500+ patients)
4. **Benchmark Baseline**: Run comprehensive evaluation with new graph-based metrics
5. **Privacy Prototype**: Start implementing basic DP noise mechanism

---

## Questions for Discussion

1. Should we prioritize MME integration or federated learning component?
2. Which real-world dataset should be primary validation target?
3. Interest in collaborating with disease advocacy groups?
4. Timeline for submitting to workshop/conference?

---

## Next Meeting

**Scheduled**: Week 2 of Winter Quarter
**Agenda**: Review PSI implementation progress, discuss real data access status

---

*Document generated following Q1 review meeting*
